PharmaCyte Biotech, Inc.

Insider Reports History

Location
Las Vegas, NV
Signature
PharmaCyte Biotech, Inc. By: /s/ Carlos A. Trujillo, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PharmaCyte Biotech, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Q/C TECHNOLOGIES, INC. 10%+ Owner Series H Convertible Preferred Stock 889,865 04 Sep 2025 Direct
Q/C TECHNOLOGIES, INC. 10%+ Owner Warrants 889,865 14 Nov 2025 Direct

Insider Reports Filed by PharmaCyte Biotech, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNFA Q/C TECHNOLOGIES, INC. 04 Sep 2025 2 $0 4 10%+ Owner 18 Nov 2025, 16:32
TNFA MyMD Pharmaceuticals, Inc. 23 May 2024 0 $0 3 10%+ Owner 30 May 2024, 16:05
FEMY FEMASYS INC 21 Nov 2023 0 $0 3 10%+ Owner 28 Nov 2023, 17:06